Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

GOLD STAR DISTRIBUTION INC

US Class II Ongoing · initiated 2025-12-26

CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.

Haleon US Holdings LLC

US Class III Ongoing · initiated 2025-12-26

Labeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.

ERYTHROMYCIN OPHTHALMIC OINTMENT USP

Canada Type II Ongoing · initiated 2025-12-23

Product quality. Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health c…

Cipla USA, Inc.

US Class III Ongoing · initiated 2025-12-22

Failed PH Specifications

Baxter Healthcare Corporation

US Class II Ongoing · initiated 2025-12-22

Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution

HANDELNINE GLOBAL LLC

US Class I Ongoing · initiated 2025-12-22

CGMP Deviations: product found to contain lead.